Spatial OMICS Market Growth & Trends
The global spatial OMICS market size is expected to reach USD 484.22 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.00% from 2021 to 2028. The COVID-19 pandemic slowed down many industries worldwide. However, this market did not face the extensive negative impact of the pandemic.
Startups and well-established players continued their product development and launched novel solutions, democratized their offerings beyond innovators, and engaged in mergers & acquisitions. The spatial OMICS field originated from hyperplexed imaging; however, key players have shifted toward the development of spatial transcriptomics solutions and products.
Rapid advances in the sequencing of tissues, genes, and single cells have resulted in the emergence of spatial genomic sequencing. Spatial OMICS techniques offer quantitative gene expression data and visualization of DNA and RNA mapping within tissue sections. The development of novel technologies for spatial OMICS is anticipated to create lucrative opportunities for the fields of translational research as well as diagnostics.
The spatial genomics technology segment is expected to expand at the fastest CAGR throughout the forecast period owing to a rise in the launch of novel platforms. The integration of high-throughput solutions in transcriptomics, genomics, and proteomics studies has enabled determining the link between disease occurrence and genome position.
The instruments product held the second-largest share in 2020 owing to the launch of new automated solutions for spatial OMIC studies. For instance, in March 2021, Rebus Biosystems launched the new Rebus Esper spatial omics platform for a better understanding of tissue biology. The new integrated and automated instrument delivers quantitative single-cell, single-molecule data with subcellular resolution and spatial context by using advanced fluidics, imaging, chemistry, and bioinformatics solutions.
The fresh frozen sample type is expected to witness significant growth over the forecast period. The advantages of fresh frozen samples in proteomics are validated by several research studies. For instance, in March 2021, a study concluded that Filter Aided Sample Preparation (FASP) technique yielded 20% more protein identifications by using fresh frozen samples than formalin-fixed, paraffin-embedded (FFPE) samples.
North America held the largest share in 2020 owing to an increase in focus on translational research, rise in government support for genomics and sequencing technologies, high demand for personalized medicine, and the presence of a substantial number of translational and academic research organizations.
Request a free sample copy or view report summary: Spatial OMICS Market Report
Spatial OMICS Market Report Highlights
- By technology, spatial transcriptomics accounted for the largest share in 2020 and is projected to maintain its dominance throughout the forecast period as most of the available products are based on mRNA analysis for positional information
- In terms of product, the consumables segment held the largest revenue share in 2020 owing to the frequent purchase of reagents and probes to run instruments
- Based on workflow, the instrumental analysis segment dominated the market in 2020 owing to the technological advancements and launch of novel products in the market
- The fresh frozen sample type is anticipated to expand at a lucrative CAGR from 2021 to 2028 as fresh frozen tissue preserves the native state of proteins and hence are adopted in spatial proteomics analysis
- On the basis of end use, the academic and translational research institutes dominated the market in 2020 owing to an increase in biomedical research in academic universities
Access Press Release@ https://www.grandviewresearch.com/press-release/global-spatial-omics-market
Spatial OMICS Market Segmentation
Grand View Research has segmented the global spatial OMICS market on the basis of technology, product, workflow, sample type, end use, and region:
Spatial OMICS Technology Outlook (Revenue, USD Million, 2017 - 2028)
- Spatial Transcriptomics
- Sequencing-based Methods
- Laser capture microdissection (LCM), by tissue type
- FFPE tissue samples
- Others
- Transcriptome in-vivo analysis (TIVA)
- In situ sequencing
- Microtomy sequencing
- FFPE tissue samples
- IHC
- Microscopy-based RNA Imaging Techniques, by methods
- Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
- Padlock Probes/ Rolling Circle Amplification
- Branched DNA probes
- Spatial Genomics
- FISH
- Microscopy-based Live DNA Imaging
- Genome Perturbation Tools
- Massively-parallel Sequencing
- Biochemical Techniques
- Others
- Spatial Proteomics
- Imaging Techniques
- Microscopy
- Multiplexed Ion Beam Imaging
- Mass Spectrometry
- Immunofluorescence Techniques
- Centrifugation Techniques
- Others
- Imaging Techniques
- Laser capture microdissection (LCM), by tissue type
- Sequencing-based Methods
Spatial OMICS Product Outlook (Revenue, USD Million, 2017 - 2028)
- Instruments
- By Mode
- Automated
- Semi-automated
- Manual
- By Type
- Sequencing Platforms
- IHC
- Microscopy
- Flow Cytometry
- Mass Spectrometry
- Others
- Consumables
- Software
- Bioinformatics tools
- Imaging tools
- Storage and management databases
- By Mode
Spatial OMICS Workflow Outlook (Revenue, USD Million, 2017 - 2028)
- Sample Preparation
- Instrumental Analysis
- Data Analysis
Spatial OMICS Sample Type Outlook (Revenue, USD Million, 2017 - 2028)
- FFPE
- Fresh Frozen
Spatial OMICS End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Academic & Translational Research Institutes
- Pharmaceutical and Biotechnology Companies
Spatial OMICS Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- France
- Spain
- Italy
- Netherlands
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Latin America
- Brazil
- MEA
- South Africa
List of Key Players of Spatial OMICS Market
- 10x Genomics
- Dovetail Genomics
- S2 Genomics, Inc.
- NanoString Technologies, Inc.
- Seven Bridges Genomics
- PerkinElmer, Inc.
- Bio-Techne
- Danaher Corporation
- IonPath, Inc.
- Millennium Science Pty Ltd.
- Akoya Biosciences, Inc.
- Fluidigm Corporation
- Diagenode Diagnostics
- Biognosys AG
- Rebus Biosystems
- Ultivue, Inc.
- Vizgen Corp.
- BioSpyder Technologies
- Bruker
- Brooks Automation, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.